PRP
GILD icon

Peak Retirement Planning’s Gilead Sciences GILD Stock Holding History

Peak Retirement Planning’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.2M Buy
25,360
+8,770
+53% +$1.16M 0.51% 61
2026
Q1 		$2.31M Sell
16,590
-17
-0.1% -$2.38K 0.46% 61
2025
Q4 		$2.04M Buy
16,607
+1,298
+8% +$158K 0.48% 57
2025
Q3 		$1.7M Buy
15,309
+3,482
+29% +$396K 0.48% 67
2025
Q2 		$1.31M Buy
11,827
+2,866
+32% +$305K 0.53% 57
2025
Q1 		$1M Sell
8,961
-105
-1% -$10.8K 0.56% 55
2024
Q4 		$837K Buy
+9,066
New +$816K 0.57% 55

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Peak Retirement Planning's GILD Position: Q2 2026 in Review

Peak Retirement Planning increased its Gilead Sciences (GILD) stake by 53% in Q2 2026, buying an estimated $1.16M and bringing the position to 25,360 shares worth $3.2M. The position accounts for 0.51% of the portfolio, ranked #61.

Peak Retirement Planning first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. 2,262 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Peak Retirement Planning held 25,360 shares of Gilead Sciences worth $3.2M as of Q2 2026.
  • Peak Retirement Planning bought 8,770 Gilead Sciences shares in Q2 2026, an estimated $1.16M.
  • Gilead Sciences made up 0.51% of Peak Retirement Planning's portfolio in Q2 2026, its #61 holding.
  • Peak Retirement Planning first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • 2,262 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Peak Retirement Planning's 13F filing for Q2 2026, filed 10 Aug 2026.